Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trial. (Q50148222)
Jump to navigation
Jump to search
scientific article published on 2 November 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trial. |
scientific article published on 2 November 2017 |
Statements
1 reference
Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trial. (English)
1 reference
Piero Ruggenenti
1 reference
Annalisa Perna
1 reference
Olimpia Diadei
1 reference
Manuela Abbate
1 reference
Nadia Rubis
1 reference
Flavio Gaspari
1 reference
Roberto Trevisan
1 reference
Aneliya Parvanova
1 reference
Fabiola Carrara
1 reference
Nadia Stucchi
1 reference
Ilian Petrov Iliev
1 reference
Barbara Ruggiero
1 reference
Francesco Peraro
1 reference
Antonio C Bossi
1 reference
Manuel A PodestÃ
1 reference
Antonio Belviso
1 reference
PROCEED Study Organization and the Scientific Writing Academy (SWA) 2016
1 reference
2 November 2017
1 reference
6
1 reference
1
1 reference
27-40
1 reference
Identifiers
1 reference
1 reference